540 related articles for article (PubMed ID: 18997794)
1. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
Zarnegar BJ; Wang Y; Mahoney DJ; Dempsey PW; Cheung HH; He J; Shiba T; Yang X; Yeh WC; Mak TW; Korneluk RG; Cheng G
Nat Immunol; 2008 Dec; 9(12):1371-8. PubMed ID: 18997794
[TBL] [Abstract][Full Text] [Related]
2. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M
Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792
[TBL] [Abstract][Full Text] [Related]
3. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
[TBL] [Abstract][Full Text] [Related]
4. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response.
Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R
Blood; 2011 Apr; 117(15):4041-51. PubMed ID: 21300983
[TBL] [Abstract][Full Text] [Related]
5. Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells.
Michel M; Wilhelmi I; Schultz AS; Preussner M; Heyd F
J Biol Chem; 2014 May; 289(19):13651-60. PubMed ID: 24671418
[TBL] [Abstract][Full Text] [Related]
6. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.
Gardam S; Sierro F; Basten A; Mackay F; Brink R
Immunity; 2008 Mar; 28(3):391-401. PubMed ID: 18313334
[TBL] [Abstract][Full Text] [Related]
7. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
Keats JJ; Fonseca R; Chesi M; Schop R; Baker A; Chng WJ; Van Wier S; Tiedemann R; Shi CX; Sebag M; Braggio E; Henry T; Zhu YX; Fogle H; Price-Troska T; Ahmann G; Mancini C; Brents LA; Kumar S; Greipp P; Dispenzieri A; Bryant B; Mulligan G; Bruhn L; Barrett M; Valdez R; Trent J; Stewart AK; Carpten J; Bergsagel PL
Cancer Cell; 2007 Aug; 12(2):131-44. PubMed ID: 17692805
[TBL] [Abstract][Full Text] [Related]
8. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
[TBL] [Abstract][Full Text] [Related]
9. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
Song YJ; Kang MS
Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
[TBL] [Abstract][Full Text] [Related]
10. TNFα induced noncanonical NF-κB activation is attenuated by RIP1 through stabilization of TRAF2.
Kim JY; Morgan M; Kim DG; Lee JY; Bai L; Lin Y; Liu ZG; Kim YS
J Cell Sci; 2011 Feb; 124(Pt 4):647-56. PubMed ID: 21266470
[TBL] [Abstract][Full Text] [Related]
11. Targeting signaling factors for degradation, an emerging mechanism for TRAF functions.
Yang XD; Sun SC
Immunol Rev; 2015 Jul; 266(1):56-71. PubMed ID: 26085207
[TBL] [Abstract][Full Text] [Related]
12. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.
Takaori-Kondo A; Hori T; Fukunaga K; Morita R; Kawamata S; Uchiyama T
Biochem Biophys Res Commun; 2000 Jun; 272(3):856-63. PubMed ID: 10860842
[TBL] [Abstract][Full Text] [Related]
13. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis.
Vince JE; Pantaki D; Feltham R; Mace PD; Cordier SM; Schmukle AC; Davidson AJ; Callus BA; Wong WW; Gentle IE; Carter H; Lee EF; Walczak H; Day CL; Vaux DL; Silke J
J Biol Chem; 2009 Dec; 284(51):35906-15. PubMed ID: 19815541
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.
Darding M; Feltham R; Tenev T; Bianchi K; Benetatos C; Silke J; Meier P
Cell Death Differ; 2011 Aug; 18(8):1376-86. PubMed ID: 21331077
[TBL] [Abstract][Full Text] [Related]
15. Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.
Demchenko YN; Glebov OK; Zingone A; Keats JJ; Bergsagel PL; Kuehl WM
Blood; 2010 Apr; 115(17):3541-52. PubMed ID: 20053756
[TBL] [Abstract][Full Text] [Related]
16. Complement membrane attack complexes activate noncanonical NF-κB by forming an Akt+ NIK+ signalosome on Rab5+ endosomes.
Jane-wit D; Surovtseva YV; Qin L; Li G; Liu R; Clark P; Manes TD; Wang C; Kashgarian M; Kirkiles-Smith NC; Tellides G; Pober JS
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9686-91. PubMed ID: 26195760
[TBL] [Abstract][Full Text] [Related]
17. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.
He JQ; Saha SK; Kang JR; Zarnegar B; Cheng G
J Biol Chem; 2007 Feb; 282(6):3688-94. PubMed ID: 17158868
[TBL] [Abstract][Full Text] [Related]
18. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
Pham LV; Fu L; Tamayo AT; Bueso-Ramos C; Drakos E; Vega F; Medeiros LJ; Ford RJ
Blood; 2011 Jan; 117(1):200-10. PubMed ID: 20889926
[TBL] [Abstract][Full Text] [Related]
19. Non-canonical NF-κB signaling activation and regulation: principles and perspectives.
Razani B; Reichardt AD; Cheng G
Immunol Rev; 2011 Nov; 244(1):44-54. PubMed ID: 22017430
[TBL] [Abstract][Full Text] [Related]
20. Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells.
McPherson AJ; Snell LM; Mak TW; Watts TH
J Biol Chem; 2012 Jun; 287(27):23010-9. PubMed ID: 22570473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
